Friday, August 13, 2010

Industry Alert: Official Call For Presenters 12th Annual Immunogenicity For Biotherapeutics

From: Anne Reel, Senior Conference Producer
Re: Call for Speakers & Presentations
Event Date: April 2010
Event Venue: Washington DC
SUBMIT YOUR PROPOSAL NOW!

The Institute for International Research (IIR) is currently seeking presenters for the 2011 12th Annual Immunogenicity for Biotherapeutics event. This 3-day event will take place April 2011 in Washington DC. We invite you to submit a proposal for a speaking opportunity directly to Anne Reel, by September 10, 2010. Please send to AReel@iirusa.com.

Submission Guidelines & Details

CUSTOMIZE YOUR CONFERENCE AGENDA!
We are currently recruiting biopharmaceutical scientists who can share NEW DATA through detailed case studies on what has worked (and what hasn't worked) for Immunogenicity related to development and validation of Immunoassays, outsourcing, technology, and more. This three day event will focus on current challenges the industry sees today and provide a forum for experts to come together and share knowledge and expertise.

Who will attend the leading industry conference on Immunogenicity? Attendees will be both new and experienced biopharmaceutical scientists working in Immunogenicity such as neutralizing assay development and validation, technology, regulatory issues, and more. We expect that the conference will attract between 150-200 attendees. We are looking for novel approaches to handling nonclinical and clinical issues including:

• Regulatory considerations
• Cell-based and ligand-binding neutralizing antibody assays
• Methods to overcome drug interference
• Development and validation of Immuno and bioassays
• Demonstration of applying PK/PD/ADA/AE to interpretation of nonclinical safety studies
• Presence of ADA in nonclinical species with no PD marker available
• Cell line changes and comparability issues - animal models?
• Patient populations with high pre-existing antibody "interference"
• Interference due to increased drug target with treatment
• Standardization of statistical analysis - confirmation cut-point
• Oligonucleotides, small peptides
• Drug conjugates
• Comparison of technologies

MAKE SURE YOUR BIGGEST ISSUES ARE ADDRESSED!
Are your biggest concerns not addressed here?
Contact Anne Reel to ensure that your pressing issue gets the attention it deserves! AReel@iirusa.com or 919-676-0306.


Do you want to reach this audience?
We have a limited number of slots available for solution providers/consultants.
People who wish to become part of the program should contact, Dave Borrok, Sponsorship Manager, at 646.895.7485 or e-mail dborrok@iirusa.com.
Sessions will be 30-45 minutes including Q & A.


Share this article with your social network, just click below to share now!


No comments :

Post a Comment